Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rheumatoid Arthritis(RA)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01905735
What this trial is testing

A Safety and Efficacy of Homeopathic Medicine Rhus Toxicodendron 30 in the Treatment of Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis.
Healthcare Homoeo Charitable Society 60
Not applicableStudy completedNCT03188081
What this trial is testing

Investigate the Effectiveness of an Education Support Program on Medication Adherence in Italian Real Life Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous (SC) Abatacept

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 171
Not applicableStudy completedNCT02101307
What this trial is testing

Multicenter, Post-marketing, Non-interventional, Observational Study in RA Patients Treated With RoActemra/Actemra (Tocilizumab)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 400
Not applicableLooking for participantsNCT06812481
What this trial is testing

Anticholinergic Burden and Osteoporosis in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)Anticholinergic Adverse ReactionFractures, Bone
Balikesir University 100
Not applicableStudy completedNCT01438892
What this trial is testing

Impact Of RA Therapy Compliance On Patient-Reported Outcomes

Who this might be right for
Rheumatoid Arthritis
Pfizer 396
Testing effectiveness (Phase 2)Study completedNCT00062465
What this trial is testing

Treating Rheumatoid Arthritis With Tripterygium Wilfordi Hook F or Sulfasalazine

Who this might be right for
Rheumatoid Arthritis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 157
Post-approval studies (Phase 4)UnknownNCT03227419
What this trial is testing

Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate Responders

Who this might be right for
Arthritis, Rheumatoid
Lille Catholic University 224
Testing effectiveness (Phase 2)Looking for participantsNCT07800871
What this trial is testing

FT839 in Autoimmune Diseases

Who this might be right for
ANCA-Associated Vasculitis (AAV)Idiopathic Inflammatory Myositis (IIM)Rheumatoid Arthritis (RA)+2 more
Fate Therapeutics 446
Early research (Phase 1)Looking for participantsNCT06978647
What this trial is testing

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Inflammatory Myopathy+5 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 12
Not applicableStudy completedNCT03993548
What this trial is testing

KickStart30: A 30-Day Intervention for Patients With Rheumatoid Arthritis (RA)

Who this might be right for
Chronic PainStressPsychological+2 more
University of Texas at Austin 13
Not applicableLooking for participantsNCT06889415
What this trial is testing

Rheumatoid Arthritis and Osteosarcopenia: Associated Factors

Who this might be right for
OsteosarcopeniaRheumatoid Arthritis (RA)Sarcopenia
Konya Beyhekim Training and Research Hospital 200
Not applicableStudy completedNCT00595894
What this trial is testing

Rheumatoid Arthritis Comorbidity: Bone Health in Men and African Americans

Who this might be right for
Rheumatoid Arthritis
University of Nebraska 1,745
Testing effectiveness (Phase 2)Looking for participantsNCT06671054
What this trial is testing

A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)
SynAct Pharma Aps 240
Large-scale testing (Phase 3)Study completedNCT02373202
What this trial is testing

A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA)

Who this might be right for
Rheumatoid Arthritis
Sanofi 91
Early research (Phase 1)Study completedNCT05638854
What this trial is testing

Evaluate Safety and Pharmacokinetics of ZB002 in Healthy Participants and Participants With Rheumatoid Arthritis

Who this might be right for
Healthy VolunteersRheumatoid Arthritis
Zenas BioPharma (USA), LLC 72
Not applicableUnknownNCT01915537
What this trial is testing

Infliximab and Classic DMARDs in the Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis（RA）
Zhang, Xiao, M.D. 170
Post-approval studies (Phase 4)Looking for participantsNCT05955066
What this trial is testing

Effect of JAK Inhibitor on Erosion Healing in RA

Who this might be right for
Rheumatoid Arthritis
Chinese University of Hong Kong 60
Large-scale testing (Phase 3)Study completedNCT02332590
What this trial is testing

Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH)

Who this might be right for
Rheumatoid Arthritis
Sanofi 369
Not applicableStudy completedNCT01981473
What this trial is testing

Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab

Who this might be right for
Rheumatoid Arthritis
Pfizer 605
Not applicableStudy completedNCT02046005
What this trial is testing

Personalized Risk Estimator for Rheumatoid Arthritis Family Study

Who this might be right for
First Degree Relatives of Rheumatoid Arthritis Patients
Brigham and Women's Hospital 238
Next Page